Noteborn M - Search Results

1

Family at last: highlights of the first international meeting on proteins killing tumour cells.

Bruno P, Brinkmann CR, Boulanger MC, Flinterman M, Klanrit P, Landry MC, Portsmouth D, Borst J, Tavassoli M, Noteborn M, Backendorf C, Zimmerman RM. Bruno P, et al. Among authors: noteborn m. Cell Death Differ. 2009 Jan;16(1):184-6. doi: 10.1038/cdd.2008.164. Cell Death Differ. 2009. PMID: 19079289 Free PMC article. No abstract available.

2

PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective cell killing.

Zimmerman R, Peng DJ, Lanz H, Zhang YH, Danen-Van Oorschot A, Qu S, Backendorf C, Noteborn M. Zimmerman R, et al. Among authors: noteborn m. Cell Death Dis. 2012 Apr 5;3(4):e291. doi: 10.1038/cddis.2012.31. Cell Death Dis. 2012. PMID: 22476099 Free PMC article.

3

Mitotic catastrophe triggered in human cancer cells by the viral protein apoptin.

Lanz HL, Zimmerman RM, Brouwer J, Noteborn MH, Backendorf C. Lanz HL, et al. Among authors: noteborn mh. Cell Death Dis. 2013 Feb 7;4(2):e487. doi: 10.1038/cddis.2013.2. Cell Death Dis. 2013. PMID: 23392175 Free PMC article.

4

Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing.

Danen-van Oorschot AA, Voskamp P, Seelen MC, van Miltenburg MH, Bolk MW, Tait SW, Boesen-de Cock JG, Rohn JL, Borst J, Noteborn MH. Danen-van Oorschot AA, et al. Among authors: noteborn mh. Cell Death Differ. 2004 May;11(5):564-73. doi: 10.1038/sj.cdd.4401391. Cell Death Differ. 2004. PMID: 14765135

5

Apoptin towards safe and efficient anticancer therapies.

Backendorf C, Noteborn MH. Backendorf C, et al. Among authors: noteborn mh. Adv Exp Med Biol. 2014;818:39-59. doi: 10.1007/978-1-4471-6458-6_3. Adv Exp Med Biol. 2014. PMID: 25001531 Review.

6

Apoptin: therapeutic potential of an early sensor of carcinogenic transformation.

Backendorf C, Visser AE, de Boer AG, Zimmerman R, Visser M, Voskamp P, Zhang YH, Noteborn M. Backendorf C, et al. Among authors: noteborn m. Annu Rev Pharmacol Toxicol. 2008;48:143-69. doi: 10.1146/annurev.pharmtox.48.121806.154910. Annu Rev Pharmacol Toxicol. 2008. PMID: 17848136 Review.

7

Additive cytotoxic effect of apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells.

Olijslagers SJ, Zhang YH, Backendorf C, Noteborn MH. Olijslagers SJ, et al. Among authors: noteborn mh. Basic Clin Pharmacol Toxicol. 2007 Feb;100(2):127-31. doi: 10.1111/j.1742-7843.2006.00016.x. Basic Clin Pharmacol Toxicol. 2007. PMID: 17244262 Free article.

8

Development and application of an in vitro apoptin kinase assay.

Lanz HL, Florea BI, Noteborn MH, Backendorf C. Lanz HL, et al. Among authors: noteborn mh. Anal Biochem. 2012 Feb 1;421(1):68-74. doi: 10.1016/j.ab.2011.10.030. Epub 2011 Oct 22. Anal Biochem. 2012. PMID: 22080040

9

Proteasomal insensitivity of apoptin in tumor cells.

Lanz HL, Suijker J, Noteborn MH, Backendorf C. Lanz HL, et al. Among authors: noteborn mh. Biochem Biophys Res Commun. 2012 May 25;422(1):169-73. doi: 10.1016/j.bbrc.2012.04.132. Epub 2012 Apr 30. Biochem Biophys Res Commun. 2012. PMID: 22575449

10

PTD4-apoptin induces Bcl-2-insensitive apoptosis in human cervical carcinoma in vitro and in vivo.

Liu XW, Yuan P, Tian J, Li LJ, Wang Y, Huang SC, Liu L, Backendorf C, Noteborn MH, Sun J. Liu XW, et al. Among authors: noteborn mh. Anticancer Drugs. 2016 Nov;27(10):979-87. doi: 10.1097/CAD.0000000000000415. Anticancer Drugs. 2016. PMID: 27548349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page